达仁堂

600329 SSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

32.5B ($4.7B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

7.3B

Net Income

2.2B

Gross Margin

N/A

Op. Margin

35.1%

Net Margin

30.3%

ROE

28.2%

ROA

20.6%

D/E

0.37

Dividend Yield

N/A

EPS

2.89

Current Ratio

2.34

Price History

Company Info

Industry	C27医药制造业
Market Segment	Main Board
Currency	CNY
Fiscal Year	2024

Business Overview

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited engages in the research, development, processing, manufacturing, and sale of traditional Chinese medicine in China. It provides pharmaceutical products for cardiovascular and cerebrovascular, skin wound repair, health preservation, respiratory, digestion, rheumatism and osteodynia, urological, gynecological and pediatric, ophthalmological, tumor, chronic, and other diseases, as well as tonic drugs. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutic...

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 达仁堂

Ticker	600329
Exchange	SSE
Sector	证监会行业分类
Industry	C27医药制造业